45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
5,960
Insurances with rates
17
CPT / HCPCS codes
1,004
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 24425_ERX | INJECTION, VALRUBICIN, INTRAVESICAL, 200 MG | $888,010 | $781,449 | — | — | 15 |
| 673 | OTHER KIDNEY AND URINARY TRACT PROCEDURES WITH MCC | $117,749 | $103,619 | — | — | 14 |
| 153644_ERX | INJECTION, NIVOLUMAB AND RELATLIMAB-RMBW, 3 MG/1 MG | $75,648 | $66,570 | — | — | 13 |
| 109950_ERX | KRYSTEXXA 8 MG/ML VIAL | $69,567 | $61,219 | — | — | 14 |
| 907 | OTHER O.R. PROCEDURES FOR INJURIES WITH MCC | $60,998 | $53,679 | — | — | 14 |
| 132317_ERX | VARIZIG 125 UNIT/1.2 ML VIAL | $57,912 | $50,963 | — | — | 14 |
| 844 | OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH CC | $57,173 | $50,312 | — | — | 14 |
| 501 | SOFT TISSUE PROCEDURES WITH CC | $56,314 | $49,556 | — | — | 14 |
| 885 | PSYCHOSES | $53,142 | $46,765 | — | — | 14 |
| 637 | DIABETES WITH MCC | $52,371 | $46,086 | — | — | 14 |
| 312 | SYNCOPE AND COLLAPSE | $51,769 | $45,556 | — | — | 14 |
| 139525_ERX | INJECTION, OCRELIZUMAB, 1 MG | $51,653 | $45,454 | — | — | 15 |
| 330 | MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH CC | $49,892 | $43,905 | — | — | 14 |
| 166 | OTHER RESPIRATORY SYSTEM O.R. PROCEDURES WITH MCC | $45,461 | $40,006 | — | — | 14 |
| 463 | WOUND DEBRIDEMENT AND SKIN GRAFT EXCEPT HAND FOR MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS WIT | $44,913 | $39,523 | — | — | 14 |
| 091 | OTHER DISORDERS OF NERVOUS SYSTEM WITH MCC | $44,246 | $38,936 | — | — | 14 |
| 398 | APPENDIX PROCEDURES WITH CC | $43,149 | $37,971 | — | — | 14 |
| 947 | SIGNS AND SYMPTOMS WITH MCC | $38,901 | $34,233 | — | — | 14 |
| 351 | INGUINAL AND FEMORAL HERNIA PROCEDURES WITH CC | $38,441 | $33,828 | — | — | 14 |
| 602 | CELLULITIS WITH MCC | $38,351 | $33,749 | — | — | 14 |
| 475 | AMPUTATION FOR MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE DISORDERS WITH CC | $38,280 | $33,687 | — | — | 14 |
| 539 | OSTEOMYELITIS WITH MCC | $38,002 | $33,442 | — | — | 14 |
| 137 | MOUTH PROCEDURES WITH CC/MCC | $37,559 | $33,052 | — | — | 14 |
| 331 | MAJOR SMALL AND LARGE BOWEL PROCEDURES WITHOUT CC/MCC | $37,117 | $32,663 | — | — | 14 |
| 561 | AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITHOUT CC/MCC | $36,034 | $31,710 | — | — | 14 |
| 377 | GASTROINTESTINAL HEMORRHAGE WITH MCC | $35,792 | $31,497 | — | — | 14 |
| 083 | TRAUMATIC STUPOR AND COMA >1 HOUR WITH CC | $35,105 | $30,892 | — | — | 14 |
| 559 | AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH MCC | $34,731 | $30,563 | — | — | 14 |
| 108042_ERX | INJECTION, CABAZITAXEL, 1 MG | $34,723 | $30,556 | — | — | 15 |
| 948 | SIGNS AND SYMPTOMS WITHOUT MCC | $34,535 | $30,391 | — | — | 14 |
| 234 | CORONARY BYPASS WITH CARDIAC CATHETERIZATION OR OPEN ABLATION WITHOUT MCC | $33,990 | $29,911 | — | — | 14 |
| 111081_ERX | INJECTION, PRALATREXATE, 1 MG | $33,938 | $29,865 | — | — | 15 |
| 914 | TRAUMATIC INJURY WITHOUT MCC | $33,741 | $29,693 | — | — | 14 |
| 231 | CORONARY BYPASS WITH PTCA WITH MCC | $33,189 | $29,206 | — | — | 14 |
| 092 | OTHER DISORDERS OF NERVOUS SYSTEM WITH CC | $32,388 | $28,501 | — | — | 14 |
| 280 | ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MCC | $32,342 | $28,461 | — | — | 14 |
| 389 | GASTROINTESTINAL OBSTRUCTION WITH CC | $32,022 | $28,180 | — | — | 14 |
| 241 | AMPUTATION FOR CIRCULATORY SYSTEM DISORDERS EXCEPT UPPER LIMB AND TOE WITHOUT CC/MCC | $31,586 | $27,796 | — | — | 14 |
| 309 | CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH CC | $31,461 | $27,686 | — | — | 14 |
| 391 | ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MCC | $31,295 | $27,540 | — | — | 14 |
| 663 | MINOR BLADDER PROCEDURES WITH CC | $30,536 | $26,872 | — | — | 14 |
| 057 | DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MCC | $29,971 | $26,375 | — | — | 14 |
| 310 | CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITHOUT CC/MCC | $29,539 | $25,994 | — | — | 14 |
| 308 | CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH MCC | $29,384 | $25,858 | — | — | 14 |
| 113024_ERX | LEUPROLIDE ACETATE (FOR DEPOT SUSPENSION), 7.5 MG | $29,202 | $25,698 | — | — | 15 |
| 949 | AFTERCARE WITH CC/MCC | $29,085 | $25,595 | — | — | 14 |
| 540 | OSTEOMYELITIS WITH CC | $29,030 | $25,546 | — | — | 14 |
| 603 | CELLULITIS WITHOUT MCC | $28,830 | $25,371 | — | — | 14 |
| 862 | POSTOPERATIVE AND POST-TRAUMATIC INFECTIONS WITH MCC | $28,804 | $25,348 | — | — | 14 |
| 146908_ERX | INJECTION, LUSPATERCEPT-AAMT, 0.25 MG | $28,549 | $25,123 | — | — | 15 |
Showing top 50 of 5,960 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.